Characterisation of UK and US COPD populations in reference to exacerbation frequency and blood eosinophils level

C. Vogelmeier (Marburg, Germany), K. Kostikas (Basel, Switzerland), J. Fang (East Hanover, United States of America), B. Jones (Cardiff, United Kingdom), C. Morgan (Cardiff, United Kingdom), R. Fogel (East Hanover, United States of America), F. Gutzwiller (Basel, Switzerland), H. Cao (East Hanover, United States of America)

Source: International Congress 2018 – Biomarkers for evaluating COPD
Session: Biomarkers for evaluating COPD
Session type: Thematic Poster
Number: 1080
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Vogelmeier (Marburg, Germany), K. Kostikas (Basel, Switzerland), J. Fang (East Hanover, United States of America), B. Jones (Cardiff, United Kingdom), C. Morgan (Cardiff, United Kingdom), R. Fogel (East Hanover, United States of America), F. Gutzwiller (Basel, Switzerland), H. Cao (East Hanover, United States of America). Characterisation of UK and US COPD populations in reference to exacerbation frequency and blood eosinophils level. 1080

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: